CellaVision AB (publ)

CLVSF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$176,860$130,309$148,429$158,297
Dep. & Amort.$41,005$39,763$40,097$33,437
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$15,412$10,392-$28,804-$11,869
Other Non-Cash-$4,015$15,972-$22,437-$20,148
Operating Cash Flow$198,438$196,436$137,285$159,717
Investing Activities
PP&E Inv.-$77,749-$31,769-$69,434-$84,306
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$581-$34
Inv. Sales/Matur.$1,743$944$0$0
Other Inv. Act.$0-$54,707$1$1
Investing Cash Flow-$76,006-$85,532-$70,014-$84,339
Financing Activities
Debt Repay.-$28,960-$31,421-$31,935-$30,587
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$53,666-$53,666-$47,703-$17,889
Other Fin. Act.-$12,463-$11,949-$10,772$1
Financing Cash Flow-$95,089-$97,036-$90,410-$48,475
Forex Effect$443-$275$906$1,122
Net Chg. in Cash$27,785$13,592-$22,233$28,024
Supplemental Information
Beg. Cash$121,645$108,053$130,286$102,262
End Cash$149,430$121,645$108,053$130,286
Free Cash Flow$120,689$109,960$67,851$75,411